🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 12529R107
- Market Cap
- Large Cap
- IPO
- 10/2/2020 · $19.00/share
Business: C4 Therapeutics, Inc. is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases, reduce drug resistance, achieve higher potency, and decrease side effects through greater selectivity.
Company Contact
- CEO
- Andrew Hirsch
- CFO
- Kendra Adams
- Headquarters
- 490 Arsenal Way, Suite 200, Watertown, MA 02472
- Phone
- 617-231-0770
- Investor Relations
- Courtney Solberg · 617-231-0770 · csolberg@c4therapeutics.com